Skip to main content

Humana guidance

  • HUM · NYSE
  • Insurance
  • Managed Health Care
  • S&P 500
$450.00+1.42%Close 13 Nov 2026 · Market value $55.10B

In its results release of 6 Nov 2026 (Q3 FY2026), Humana gave 2 forecasts in figures, among them EPS (gaap) of $16.84 for FY2026.

Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.

Latest guidance given with Q3 FY2026 results, 6 Nov 2026

MeasurePeriodGuidanceAs stated
EPS · GAAPFY2026$16.84Reports 3Q26 earnings per share (EPS) of $1.33 on a GAAP basis, Adjusted loss per share of $0.70; reports year to date (YTD) 2026 EPS of $16.84 on a GAAP basis, $17.17 on an Adjusted basis
EPS · AdjustedFY2026$17.17Reports 3Q26 earnings per share (EPS) of $1.33 on a GAAP basis, Adjusted loss per share of $0.70; reports year to date (YTD) 2026 EPS of $16.84 on a GAAP basis, $17.17 on an Adjusted basis

Source: the company's earnings release.

Guidance against results last two years

The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.

MeasurePeriodLast guidanceRevisionsDeliveredResult
EPS · GAAPFY2026$16.84Raised once—To come
EPS · AdjustedFY2026$17.17Lowered once—To come

HUM in the terminal

Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.